Double Trouble: Dual Positivity for Antiglomerular Basement Membrane Antibody and proteinase-3-antineutrophil Cytoplasmic Antibody Presenting as Rapidly Progressive Glomerulonephritis
- 1Department of Nephrology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
Abstract
Antiglomerular basement membrane (anti-GBM) disease and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are uncommon causes of rapidly progressive glomerulonephritis. Their coexistence, termed double-positive disease, is rare and associated with severe renal and pulmonary manifestations. A 27-year-old male came with complaints of inflammatory polyarthralgia followed by progressive dyspnea and hemoptysis. Investigations revealed azotemia, active urinary sediment with proteinuria, bilateral pulmonary infiltrates, and dual seropositivity for anti-GBM antibodies and proteinase-3-ANCA. A diagnosis of double-positive vasculitis with pulmonary-renal syndrome was made. The treatment of the patient started with intravenous methylprednisolone, therapeutic plasma exchange, and intravenous cyclophosphamide, followed by oral glucocorticoids. Renal function improved significantly, with serum creatinine decreasing from 2.44 mg/dL at presentation to 1.42 mg/dL at discharge. The patient remained clinically stable during follow-up. Double-positive anti-GBM and ANCA disease represents a distinct clinical entity with overlapping features of both conditions. Early recognition and aggressive immunosuppressive therapy can result in favorable renal outcomes.
Related
- Real‐World Use of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Early and Long‐Term Clinical, Renal, and Patient‐Reported Outcomes in an Italian Rheumatology–Nephrology Network
- Biopsy-proven Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-associated Vasculitis Overlap Syndrome Developed during Propylthiouracil Therapy: A Case-based Review
- Inflammatory regulatory mechanisms and targeted therapy of antineutrophil cytoplasmic antibodies in atherosclerosis (Review)
- Rapidly progressive glomerulonephritis revealing the coexistence of diabetic nephropathy, membranous nephropathy, and MPO-ANCA-associated crescentic glomerulonephritis.
- Glomerulonephritis in the owl monkey (Aotus trivirgatus): ultrastructural observations
BibTeX
@article{singh2026double,
title = {{Double Trouble: Dual Positivity for Antiglomerular Basement Membrane Antibody and proteinase-3-antineutrophil Cytoplasmic Antibody Presenting as Rapidly Progressive Glomerulonephritis}},
author = {Sahibjeet Singh and Charan Bale and Pavan Wakhare},
journal = {Annals of African Medicine},
year = {2026},
month = jun,
doi = {10.4103/aam.aam_105_26},
url = {https://doi.org/10.4103/aam.aam_105_26},
note = {CC BY-NC-SA 4.0},
}
RIS
TY - JOUR
TI - Double Trouble: Dual Positivity for Antiglomerular Basement Membrane Antibody and proteinase-3-antineutrophil Cytoplasmic Antibody Presenting as Rapidly Progressive Glomerulonephritis
AU - Sahibjeet Singh
AU - Charan Bale
AU - Pavan Wakhare
PY - 2026
DA - 2026/06/05
JO - Annals of African Medicine
DO - 10.4103/aam.aam_105_26
UR - https://doi.org/10.4103/aam.aam_105_26
AB - Antiglomerular basement membrane (anti-GBM) disease and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are uncommon causes of rapidly progressive glomerulonephritis. Their coexistence, termed double-positive disease, is rare and associated with severe renal and pulmonary manifestations. A 27-year-old male came with complaints of inflammatory polyarthralgia followed by progressive dyspnea and hemoptysis. Investigations revealed azotemia, active urinary sediment with proteinuria, bilateral pulmonary infiltrates, and dual seropositivity for anti-GBM antibodies and proteinase-3-ANCA. A diagnosis of double-positive vasculitis with pulmonary-renal syndrome was made. The treatment of the patient started with intravenous methylprednisolone, therapeutic plasma exchange, and intravenous cyclophosphamide, followed by oral glucocorticoids. Renal function improved significantly, with serum creatinine decreasing from 2.44 mg/dL at presentation to 1.42 mg/dL at discharge. The patient remained clinically stable during follow-up. Double-positive anti-GBM and ANCA disease represents a distinct clinical entity with overlapping features of both conditions. Early recognition and aggressive immunosuppressive therapy can result in favorable renal outcomes.
SN - 1596-3519
SN - 0975-5764
ER -